Siew C Ng1, Francis K L Chan. 1. Institute of Digestive Disease, Chinese University of Hong Kong, Department of Medicine and Therapeutics, Prince of Wales Hospital, Shalin, NT, Hong Kong.
Abstract
PURPOSE OF REVIEW: To review recent publications related to NSAID-induced adverse effects on the gastrointestinal and cardiovascular systems. RECENT FINDINGS: This paper explores novel mechanisms of NSAID-induced gastrointestinal injury, highlights new composite endpoints evaluating adverse events of NSAIDs in the entire gastrointestinal tract, and combines published data to establish evidence-based guidance on the best use of NSAIDs to achieve optimal clinical outcomes whilst minimizing cardiovascular and gastrointestinal injuries. SUMMARY: NSAIDs can induce peptic ulcers via epithelial cell membrane disruption and the renin angiotensin system, independent of the cyclooxygenase (COX) pathways, whereas mast cells and bile acid sensors may have a protective effect on NSAID-induced gastrointestinal damage. Patients with arthritis treated with a COX-2 inhibitor are less likely to develop upper and lower gastrointestinal complications than those who are treated with diclofenac plus a proton pump inhibitor (PPI). PPI therapy is recommended in patients receiving dual antiplatelet treatment but observational studies show that clopidogrel users taking PPIs have an increased risk of cardiovascular events. Until further reliable controlled data are available, this potential, but currently unproven, clinical interaction can be minimized by widely separating the dosing of clopidogrel and PPI. Histamine-2 antagonists may be an alternative to PPI for the prevention of peptic ulcers in patients taking low-dose aspirin.
PURPOSE OF REVIEW: To review recent publications related to NSAID-induced adverse effects on the gastrointestinal and cardiovascular systems. RECENT FINDINGS: This paper explores novel mechanisms of NSAID-induced gastrointestinal injury, highlights new composite endpoints evaluating adverse events of NSAIDs in the entire gastrointestinal tract, and combines published data to establish evidence-based guidance on the best use of NSAIDs to achieve optimal clinical outcomes whilst minimizing cardiovascular and gastrointestinal injuries. SUMMARY: NSAIDs can induce peptic ulcers via epithelial cell membrane disruption and the renin angiotensin system, independent of the cyclooxygenase (COX) pathways, whereas mast cells and bile acid sensors may have a protective effect on NSAID-induced gastrointestinal damage. Patients with arthritis treated with a COX-2 inhibitor are less likely to develop upper and lower gastrointestinal complications than those who are treated with diclofenac plus a proton pump inhibitor (PPI). PPI therapy is recommended in patients receiving dual antiplatelet treatment but observational studies show that clopidogrel users taking PPIs have an increased risk of cardiovascular events. Until further reliable controlled data are available, this potential, but currently unproven, clinical interaction can be minimized by widely separating the dosing of clopidogrel and PPI. Histamine-2 antagonists may be an alternative to PPI for the prevention of peptic ulcers in patients taking low-dose aspirin.
Authors: Justin R Piro; Daniel I Benjamin; James M Duerr; YeQing Pi; Cathleen Gonzales; Kathleen M Wood; Joel W Schwartz; Daniel K Nomura; Tarek A Samad Journal: Cell Rep Date: 2012-06-21 Impact factor: 9.423
Authors: Michael L Kent; Patrick J Tighe; Inna Belfer; Timothy J Brennan; Stephen Bruehl; Chad M Brummett; Chester C Buckenmaier; Asokumar Buvanendran; Robert I Cohen; Paul Desjardins; David Edwards; Roger Fillingim; Jennifer Gewandter; Debra B Gordon; Robert W Hurley; Henrik Kehlet; John D Loeser; Sean Mackey; Samuel A McLean; Rosemary Polomano; Siamak Rahman; Srinivasa Raja; Michael Rowbotham; Santhanam Suresh; Bernard Schachtel; Kristin Schreiber; Mark Schumacher; Brett Stacey; Steven Stanos; Knox Todd; Dennis C Turk; Steven J Weisman; Christopher Wu; Daniel B Carr; Robert H Dworkin; Gregory Terman Journal: J Pain Date: 2017-05 Impact factor: 5.820
Authors: Daniel K Nomura; Bradley E Morrison; Jacqueline L Blankman; Jonathan Z Long; Steven G Kinsey; Maria Cecilia G Marcondes; Anna M Ward; Yun Kyung Hahn; Aron H Lichtman; Bruno Conti; Benjamin F Cravatt Journal: Science Date: 2011-10-20 Impact factor: 47.728
Authors: José Pedro Henriques Patrício; Jorge Pinto Pereira Barbosa; Rui Miguel Monteiro Ramos; Nuno Filipe Pimenta Antunes; Pedro Carlos Santos de Melo Journal: Clin Drug Investig Date: 2013-03 Impact factor: 2.859
Authors: Iris Gehrke; Regina Razavi; Simon Jonas Poll-Wolbeck; Albrecht Berkessel; Michael Hallek; Karl-Anton Kreuzer Journal: Ther Adv Hematol Date: 2011-10